orchid cellmark inc. Resources | BNET
On GameSpot: Halo 3 leads Xbox Live holiday deals

BNET Industries

Orchid Cellmark Inc. (ORCH) is in the Business Services Industry

Revenue
Dec 31 2007
$60.3M
Profit
Dec 31 2007
($2.9M)
Market Cap
Dec 03 2008
$26.9M

Latest News and Analysis

Additional Resources

  • Zacks Analyst Blog Highlights: Gushan Environmental Energy Ltd., ZOLL Medical Corp., ArthroCare Corp., Orchid Cellmark, Inc. and Charlotte Russe Holdings, Inc

    CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Gushan Environmental Energy Ltd. (NYSE: GU), ZOLL Medical Corp. (Nasdaq: ZOLL),...

    Articles 2008-10-08

  • MEDIA ALERT: Data Domain Customers to Present at Gartner IT Infrastructure, Operations & Management Summit

    Data Domain (NASDAQ: DDUP) customers OrchidCellmark, EBSCO Industries and PSS World Medical will be speaking at ITInfrastructure, Operations & Management Summit, taking place June 23-25 atthe J.W. Marriott Grande Lakes in Orlando, FL. The organizations will bediscussing their enterprise implementations of Data Domain's deduplicationstorage systems. The intent of the Gartner...

    Articles 2008-06-20

  • Beckman files suit against Sequenom

    San Diego, CA 6/5/08; Washington, DC 6/9/08--Beckman Coulter and Orchid Cellmark have filed a patent infringement suit against Sequenom in the US District Court of the Southern District of California. The suit alleges that Sequenom's iPLEX products for SNP genotyping infringe three patents exclusively licensed to Beckman Coulter by Orchid...

    Articles 2008-06-15

  • Has added Orchid Cellmark Inc. to their watch list.

    M2 PRESSWIRE-7 March 2008-MG Strategies: Has added Orchid Cellmark Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:07032008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers, researchers, and...

    Articles 2008-03-07

  • Orchid Cellmark Inc. Review in Progress.

    M2 PRESSWIRE-6 March 2008-Market Review: Orchid Cellmark Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:06032008 Streetinvesting.com has now resumed our progressive review of Orchid Cellmark Inc. (Nasdaq: ORCH) after it traded down 16% Thursday, early in the afternoon with...

    Articles 2008-03-06

  • Special Alert Stock Watch: EXPT! December 5, 2007

    Stock Market Alerts' performance stock listincludes: Expert Group, Inc. (PINKSHEETS: EXPT), Zix Corporation (NASDAQ: ZIXI), Arrow Electronics, Inc. (NYSE: ARW), Orchid Cellmark Inc (NASDAQ: ORCH). Having just recently began trading, Expert Group, Inc. (PINKSHEETS: EXPT)is a new stock to watch as Stock Market Alerts initiates coverage of thecompany. Tuesday after...

    Articles 2007-12-05

  • Orchid Cellmark to purchase ReliaGene.

    Orchid Cellmark, Inc. (Princeton, NJ), a leading worldwide provider of identity DNA testing services, announced that it has signed a definitive purchase agreement to acquire the outstanding stock of ReliaGene Technologies, Inc. (New Orleans, LA) for a purchase price of $5.6 million in cash and $3.0...

    Articles 2007-09-01

  • DNA Test Wins Innocent's Release

    DNA tests conducted by Orchid Cellmark Inc. of Princeton paved the way for Byron Halsey to be acquitted and walk away free last week, after he was wrongfully sentenced to prison for a 1985 brutal double murder in Elizabeth. Orchid, which specializes in identity DNA testing, performed the tests...

    Articles 2007-07-16

  • Trading Alert for Orchid Cellmark Inc.

    M2 PRESSWIRE-4 May 2007-Biotech News: Trading Alert for Orchid Cellmark Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:04052007 Matchmaker, matchmaker, make me a genetic match! Orchid Cellmark uses its expertise in single nucleotide polymorphisms SNPs, markers of genetic diversity, to be a leader in...

    Articles 2007-05-04

  • Orchid Cellmark Inc. Posts Q1 Results.

    M2 PRESSWIRE-4 May 2007-NASDAQNEWS: Orchid Cellmark Inc. Posts Q1 ResultsC1994-2007 M2 COMMUNICATIONS LTD RDATE:04052007 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have a stock...

    Articles 2007-05-04

  • Analysis of Orchid Cellmark Inc.

    M2 PRESSWIRE-28 March 2007-Biotech News: Analysis of Orchid Cellmark IncC1994-2007 M2 COMMUNICATIONS LTD RDATE:28032007 Analysis of Orchid Cellmark Inc (NASDAQ:ORCH) Orchid Cellmark, Inc. provides identity DNA testing services for the human identity and agriculture markets. Its services generate ...

    Articles 2007-03-28

  • Terrorist attack on LGC

    A woman was injured when a letter bomb was sent to Oxfordshire science firm Orchid Cellmark on 18 January. Four and a half hours later, a second letter bomb was sent to the offices of LGC formerly Laboratory of the Government Chemist Forensics, but no one was hurt. ...

    Articles 2007-01-29

  • CRH, PRW, ARCAF, ECHO, ORCH, PRGX Have Been Removed From Naked Short List Today.

    M2 PRESSWIRE-24 January 2007-BUYINS.NET: CRH, PRW, ARCAF, ECHO, ORCH, PRGX Have Been Removed From Naked Short List TodayC1994-2007 M2 COMMUNICATIONS LTD RDATE:24012007 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short...

    Articles 2007-01-24

  • PRW, WFD, ORCH, PRGX, ARCAF, CYTO Have Been Added To Naked Short List Today.

    M2 PRESSWIRE-17 January 2007-BUYINS.NET: PRW, WFD, ORCH, PRGX, ARCAF, CYTO Have Been Added To Naked Short List TodayC1994-2007 M2 COMMUNICATIONS LTD RDATE:17012007 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short...

    Articles 2007-01-17

  • In-Depth Research on Orchid Cellmark Inc.

    M2 PRESSWIRE-21 November 2006-Biotech News: In-Depth Research on Orchid Cellmark Inc.C1994-2006 M2 COMMUNICATIONS LTD RDATE:21112006 Matchmaker, matchmaker, make me a match! Orchid Cellmark (NASDAQ:ORCH) uses its expertise in single nucleotide polymorphisms SNPs, markers of genetic diversity, to be a leader in...

    Articles 2006-11-21

  • page 1 of 1
  • Incorporated: 1995
  • CEO: Mr. Thomas A. Bologna

Orchid Cellmark is engaged in providing deoxyribonucleic acid (DNA) testing services that generate genetic profile information by analyzing an organism's unique genetic identity. Co.'s business is focused on DNA testing for human identity as well as for animal and agricultural applications. In the human identity area, Co. provides DNA testing services for forensic, family relationship and security applications. In agricultural applications, Co. provides DNA testing services for food safety and selective trait breeding. Co. provides its DNA testing services to government agencies, private individuals and commercial companies primarily in the U.S. and the U.K.

Key Competitors

advertisement
Orchid Cellmark Inc. Company Info

Board of Directors

Dr. George H. Poste D.V.M.,

Chairman

Mr. James Beery

Dr. Sidney M. Hecht Ph.D.

Dr. Kenneth D. Noonan Ph.D.

Ms. Nicole S. Williams

Mr. Thomas A. Bologna

Contact Information

4390 US Route One

Princeton, NJ

http://www.orchid.com

609 750-2200

NAICS Code

Testing Laboratories: 541380
advertisement